We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+3.73%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$196M
AUM Growth
+$16.9M
Cap. Flow
+$11.5M
Cap. Flow %
5.88%
Top 10 Hldgs %
45.53%
Holding
92
New
22
Increased
23
Reduced
22
Closed
6

Top Buys

Rank Stock Value
1
TPB icon
Turning Point Brands
TPB
+$3.38M
2
GDX icon
VanEck Gold Miners ETF
GDX
+$1.73M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.45M
4
IBB icon
iShares Biotechnology ETF
IBB
+$1.36M
5
SLV icon
iShares Silver Trust
SLV
+$1.14M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.53M
2
AMD icon
Advanced Micro Devices
AMD
+$1.49M
3
GLD icon
SPDR Gold Trust
GLD
+$1.17M
4
TBHC
The Brand House Collective
TBHC
+$954K
5
LOW icon
Lowe's Companies
LOW
+$770K

Sector Composition

Rank Sector Weight
1 Healthcare 35.09%
2 Technology 12.85%
3 Communication Services 9.63%
4 Financials 3.93%
5 Consumer Staples 2.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGEN
26
DELISTED
Seagen Inc. Common Stock
SGEN
$2.54M 1.3%
13,000
-1,000
-7% -$167K
BMY icon
27
Bristol-Myers Squibb
BMY
$133B
$2.5M 1.28%
41,500
+1,500
+4% +$90.3K
AOD
28
abrdn Total Dynamic Dividend Fund
AOD
$1.11B
$2.27M 1.16%
286,417
+1,500
+0.5% +$12K
MSFT icon
29
PUT
Microsoft
MSFT
$3.45T
$2.1M 1.08%
+10,000
New +$2.1M
ESPR
30
DELISTED
Esperion Therapeutics
ESPR
$2.1M 1.07%
56,500
+8,000
+16% +$317K
XLNX
31
DELISTED
Xilinx Inc
XLNX
$2.06M 1.05%
19,750
-2,750
-12% -$282K
ALXN
32
DELISTED
Alexion Pharmaceuticals
ALXN
$1.49M 0.76%
13,000
– –
IBB icon
33
iShares Biotechnology ETF
IBB
$9.34B
$1.35M 0.69%
+10,000
New +$1.36M
LOW icon
34
Lowe's Companies
LOW
$117B
$1.24M 0.64%
7,500
-5,000
-40% -$770K
ARNA
35
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.2M 0.61%
16,000
– –
CSCO icon
36
Cisco
CSCO
$457B
$1.18M 0.6%
30,000
+5,000
+20% +$218K
MU icon
37
PUT
Micron Technology
MU
$930B
$1.17M 0.6%
+25,000
New +$1.21M
INTC icon
38
Intel
INTC
$455B
$1.17M 0.6%
22,500
+7,500
+50% +$390K
STEW
39
SRH Total Return Fund
STEW
$1.79B
$1.13M 0.58%
112,793
+24,110
+27% +$241K
SLV icon
40
iShares Silver Trust
SLV
$28B
$1.08M 0.55%
+50,000
New +$1.14M
AMRN
41
Amarin Corp
AMRN
$298M
$1.05M 0.54%
12,488
+2,825
+29% +$339K
KWEB icon
42
KraneShares CSI China Internet ETF
KWEB
$5.64B
$1.02M 0.52%
+15,000
New +$1.02M
NOK icon
43
Nokia
NOK
$51B
$1.02M 0.52%
260,000
+45,000
+21% +$202K
KYNB
44
Kyntra Bio
KYNB
$27.2M
$987K 0.5%
960
+580
+153% +$624K
AAPL icon
45
Apple
AAPL
$4.54T
$926K 0.47%
8,000
– –
IBM icon
46
IBM
IBM
$211B
$913K 0.47%
7,845
– –
GMAB icon
47
Genmab
GMAB
$17.7B
$897K 0.46%
24,500
+12,000
+96% +$434K
ORCL icon
48
CALL
Oracle
ORCL
$374B
$896K 0.46%
15,000
-7,500
-33% -$426K
VIR icon
49
Vir Biotechnology
VIR
$1.46B
$893K 0.46%
26,000
+18,500
+247% +$796K
BOX icon
50
Box
BOX
$4.37B
$868K 0.44%
50,000
– –
1
2
3 4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q3 2020 Portfolio in Review

As of Q3 2020, DCF Advisers held 92 positions worth $196M, up 9.4% from $179M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

DCF Advisers deployed $11.5M of net new capital in Q3 2020, opening 22 new positions and adding to 23 existing holdings. Its largest new stake was iShares Biotechnology ETF: 10,000 shares worth $1.35M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 38% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $1.53M trimmed.

  • DCF Advisers's largest Q3 2020 buy was iShares Biotechnology ETF: 10,000 shares worth $1.35M.
  • DCF Advisers added most to Turning Point Brands in Q3 2020, an estimated $3.38M increase.
  • DCF Advisers's biggest Q3 2020 reduction was Berkshire Hathaway Class B, cutting an estimated $1.53M.
  • DCF Advisers's ten largest holdings make up 46% of its $196M portfolio in Q3 2020.
  • DCF Advisers opened 22 new positions and closed 6 in Q3 2020.
  • DCF Advisers's portfolio value rose 9.4% quarter-over-quarter to $196M.

Based on DCF Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.